电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant Uroplakin 2 抗体 (AA 36-51)

The 兔 单克隆 anti-Uroplakin 2 antibody (Clone UPK2-13348R) (ABIN8093556) specifically detects Uroplakin 2 in IHC. The antibody is reactive with 人 samples.
产品编号 ABIN8093556
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant Uroplakin 2 抗体 (AA 36-51) (ABIN8093556)

抗原

See all Uroplakin 2 (UPK2) 抗体
Uroplakin 2 (UPK2)

抗体类型

Recombinant Antibody

适用

  • 21
  • 4
  • 1
人

宿主

  • 23
  • 1
兔

克隆类型

  • 15
  • 9
单克隆

标记

  • 18
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Uroplakin 2 antibody is un-conjugated

应用范围

  • 15
  • 10
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
Immunohistochemistry (IHC)

质量等级

Carrier-free

克隆位点

UPK2-13348R
  • 抗原表位

    • 7
    • 6
    • 2
    • 1
    • 1
    • 1
    AA 36-51

    原理

    UPK2 Antibody / Uroplakin 2 (azide and preservative free)

    纯化方法

    Protein A affinity

    免疫原

    A recombinant fragment (around amino acids 36-51) of human Uroplakin 2 (UPK2) protein (exact sequence is proprietary) was used as the immunogen for the Uroplakin 2/UPK2 antibody.

    亚型

    IgG, kappa
  • 应用备注

    1. Optimal dilution of the Uroplakin 2/UPK2 antibody should be determined by the researcher.

    2. This Uroplakin 2/UPK2 antibody is recombinantly produced by expression in CHO cells.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    1 mg/mL

    缓冲液

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    储存液

    Azide free

    储存条件

    -20 °C,-80 °C

    储存方法

    Uroplakin 2/UPK2 antibody with sodium azide - store at 2 to 8oC, antibody without sodium azide - store at -20 to -80oC.
  • 抗原

    Uroplakin 2 (UPK2)

    别名

    UPK2

    背景

    Uroplakin 2 antibody recognizes Uroplakin 2, a urothelial differentiation protein encoded by the human UPK2 gene and a key structural component of the urothelial plaque. Uroplakin 2, also referred to as UPK2, is selectively expressed in the superficial umbrella cells of the urothelium lining the urinary bladder, ureters, and renal pelvis. Because of its restricted tissue distribution, Uroplakin 2 antibody is widely used in research investigating urothelial biology and bladder carcinoma.

    Uroplakin 2 is a member of the uroplakin family, which includes UPK1A, UPK1B, UPK2, and UPK3A. These proteins assemble into heterodimeric complexes that form highly ordered crystalline plaques on the apical surface of umbrella cells. Uroplakin 2 pairs specifically with Uroplakin 1A, forming a heterodimer that is incorporated into larger hexagonal arrays within the asymmetric unit membrane. These plaques provide structural rigidity and create a permeability barrier that protects underlying tissues from urine toxicity and mechanical stress. Detection of Uroplakin 2 therefore reflects terminal urothelial differentiation and specialized apical membrane architecture.

    UPK2 is localized predominantly to the apical plasma membrane of differentiated umbrella cells, where it contributes to barrier integrity and bladder surface stability. Expression is largely confined to urothelial tissue, making Uroplakin 2 a highly specific marker of urothelial origin. In pathologic settings, UPK2 expression is retained in many urothelial carcinomas, including invasive bladder carcinoma and metastatic urothelial tumors, supporting its utility in studies of tumor lineage and differentiation status.

    The UPK2 gene is located on chromosome 11q23 and encodes a glycosylated membrane protein that undergoes post-translational processing and assembly within the endoplasmic reticulum before trafficking to the apical surface. Uroplakin 2 antibody clone UPK2/13348R is a recombinant rabbit monoclonal antibody developed to detect UPK2 in research applications, supporting studies of urothelial differentiation and bladder tumor characterization.

    UniProt

    O00526
You are here: